Injectable hydrogel fills surgical cavities to keep brain cancer at bay

Glioblastoma is one of the most deadly forms of cancer, often returning with a vengeance after surgery to remove it. Researchers at the University of Wisconsin-Madison have now developed an immunity-boosting hydrogel that can be injected into the brain… Continue reading Injectable hydrogel fills surgical cavities to keep brain cancer at bay

Light-activated “photoimmunotherapy” kills brain cancer, reduces relapse

Scientists at the Institute of Cancer Research in London have developed a new light-activated “photoimmunotherapy” that could help treat brain cancer. The key is a compound that glows under light to guide surgeons to the tumor, while near-infrared ligh… Continue reading Light-activated “photoimmunotherapy” kills brain cancer, reduces relapse

Experimental brain-on-a-chip better screens brain cancer treatments

The blood-brain barrier (BBB) is a vital line of defense to keep your brain safe from toxins, but frustratingly it can sometimes be too restrictive, keeping important drugs out. Researchers at MIT have now demonstrated an accurate new model of how this… Continue reading Experimental brain-on-a-chip better screens brain cancer treatments

Pre-made stem cells may be pulled off the shelf to treat aggressive cancer

Stem cells that can be engineered to take on different properties continue to show huge potential in all areas of medicine, ranging from Parkinson’s disease treatments to regenerative therapies for injured tendons. Scientists adapting this technology f… Continue reading Pre-made stem cells may be pulled off the shelf to treat aggressive cancer

Pre-made stem cells may be pulled off the shelf to treat aggressive cancer

Stem cells that can be engineered to take on different properties continue to show huge potential in all areas of medicine, ranging from Parkinson’s disease treatments to regenerative therapies for injured tendons. Scientists adapting this technology f… Continue reading Pre-made stem cells may be pulled off the shelf to treat aggressive cancer

Cancer risk increased by wildfire exposure, first-of-its-kind study finds

A first-of-its-kind study from researchers at McGill University has investigated the relationship between certain cancers and people living in close proximity to wildfires. The findings revealed higher rates of brain tumors and lung cancer in populatio… Continue reading Cancer risk increased by wildfire exposure, first-of-its-kind study finds

No link between cell phone use and brain tumors, Oxford study finds

A new study from the International Agency for Research on Cancer and the University of Oxford is reporting on an ongoing project that has been tracking the health of nearly one million women in the UK for more than 20 years. The findings indicate there… Continue reading No link between cell phone use and brain tumors, Oxford study finds

Ultrasound and blood test could replace invasive brain cancer biopsies

Glioblastoma is a type of brain cancer that can be aggressive and, unfortunately, tricky to diagnose without a risky biopsy. But a new noninvasive method, tested in mice and pigs, could one day diagnose the disease with ultrasound pulses and a basic bl… Continue reading Ultrasound and blood test could replace invasive brain cancer biopsies

Protein discovery pulls at the roots of recurring brain cancer

Glioblastoma is an aggressive form of brain cancer, and compounding the threat is the high probability of recurrence following treatment, with dormant tumor cells springing back into action and giving rise to new growths. In a development likened to ta… Continue reading Protein discovery pulls at the roots of recurring brain cancer

What role can urine testing play in the future of cancer diagnosis?

In the wide-ranging search for new weapons against cancer, some see great potential in the idea of a urine test that can reveal telltale signs of the disease. What this could look like and what role it might play in diagnosis and treatment are question… Continue reading What role can urine testing play in the future of cancer diagnosis?